Our services encompass a wide range of specialties, including precision medicine, immunotherapy, targeted therapies, and minimally invasive surgical techniques. NewYork-Presbyterian’s commitment to research and clinical trials allows patients to participate in groundbreaking studies, offering access to emerging therapies that may shape the future of cancer treatment.
Cancer services & specialties
All specialties
- AAnal Cancer
- BBladder Cancer
- Blood Cancer
- Bone Cancer
- Brain Cancer
- Breast Cancer
- CCervical Cancer
- Colon Cancer
- EEndocrine Cancer
- Esophageal Cancer
- Eye Cancer
- GGastrointestinal Cancer
- Genetic Counseling
- Gynecologic Cancer
- HHead & Neck Cancer
- Hodgkin’s Lymphoma
- IInterventional Radiology
- KKidney Cancer
- LLaryngeal Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma
- MMelanoma
- Metastatic Cancer
- Myelodysplastic Syndrome (MDS)
- Myeloma/Multiple Myeloma
- Myeloproliferative Disorders
- NNon-Hodgkin’s Lymphoma
- OOral Cancer
- Ovarian Cancer
- PPancreatic Cancer
- Pediatric Cancer
- Penile Cancer
- Pharyngeal Cancer
- Prostate Cancer
- SSarcoma (Soft Tissue and Bone Cancer)
- Skin Cancer
- Spinal Tumors in Adults
- Stomach Cancer
- TTesticular Cancer
- Thyroid Cancer
- UUrologic Cancer
- Uterine Cancer
- VVaginal Cancer
- Vulvar Cancer
Clinical Trials
When you come to NewYork-Presbyterian for cancer care, you'll have access to the latest treatments as well as options that are based on the most promising discoveries in cancer research. These investigational approaches are available through clinical trials. Virtually every advance ever made in the management of cancer — from new treatments to diagnostic methods to prevention strategies — has been assessed in a clinical trial. These important studies are conducted by investigators at the Herbert Irving Comprehensive Cancer Center of Columbia University and the Weill Cornell Medicine Meyer Cancer Center. Many of our physicians have led the development and evaluation of cancer treatments that are now the standard of care across the world.
Columbia University Herbert Irving Comprehensive Cancer Center Clinical Trials